Free Trial

Tonix Pharmaceuticals (TNXP) SEC Filings & 10K Form

Tonix Pharmaceuticals logo
$0.61 +0.04 (+7.30%)
(As of 12/20/2024 05:45 PM ET)

Recent Tonix Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/17/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:13 PM
Tonix Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/03/2024
4:15 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
12/03/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
8:10 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
4:10 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:30 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
8:01 AM
Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
10/16/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
11:15 PM
Tonix Pharmaceuticals (Filer)
Form EFFECT
09/27/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
4:09 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
09/23/2024
6:08 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
4:03 PM
Tonix Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/19/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
6:23 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:00 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
09/10/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
4:17 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:04 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
08/30/2024
4:08 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
6:02 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
5:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:18 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/15/2024
5:03 AM
Tonix Pharmaceuticals (Filer)
Form NT 10-Q
08/12/2024
7:18 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:22 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:08 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
4:17 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
07/25/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
4:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
07/16/2024
8:12 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:48 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.

07/09/2024
3:33 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
07/08/2024
4:01 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
07/08/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
5:45 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
4:25 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:09 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
06/26/2024
3:52 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
06/26/2024
3:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:25 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
06/13/2024
4:24 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:49 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
06/10/2024
7:53 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
10:21 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
4:10 PM
Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:56 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:49 PM
Tonix Pharmaceuticals (Filer)
Form ARS
04/15/2024
3:38 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
04/05/2024
3:47 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
03/29/2024
4:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:03 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
8:23 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
8:48 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:01 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4/A
03/06/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:05 PM
SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:06 PM
MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:08 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:31 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:53 PM
Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:33 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
Buy this coin BEFORE Inauguration Day … (Ad)

Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.

01/02/2024
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
12/26/2023
4:25 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
12/21/2023
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TNXP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners